Read Gene Spolka Akcyjna
Develops DNA tests to identify genetic cancer risk for early detection and prevention.
RDG | WAR
Overview
Corporate Details
- ISIN(s):
- PLRADGN00014 (+1 more)
- LEI:
- 2594003D7O7NDUV8GE29
- Country:
- Poland
- Address:
- Dobra Grzepnica-Alabastrowa 8, 72-003 Dobra
- Website:
- http://www.read-gene.com
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Read-Gene S.A. is an innovative biotechnology company focused on the commercialization of methods for the detection, prevention, and treatment of malignant tumors. Established in 2005, the company's core operations are centered on three complementary segments: genetic testing, chemoprevention, and clinical trials. It develops and provides advanced DNA tests that identify genetic predispositions to cancer, enabling precise prophylaxis and facilitating earlier treatment. Additionally, the company offers advisory and support services for oncological genetic counseling centers. Read-Gene is distinguished by its strong scientific foundation, with a team of renowned scientists from the International Hereditary Cancer Center, and holds numerous patents for its novel cancer risk assessment technologies.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Read Gene Spolka Akcyjna and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2024-03-25 10:54 |
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
|
Polish | 1.0 KB | |
| 2024-03-25 10:51 |
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
|
Polish | 1.1 KB | |
| 2023-11-22 16:45 |
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
|
Polish | 1.2 KB | |
| 2023-11-16 17:31 |
Legal Proceedings Report
Decyzja o ochronie patentowej na wynalazek - Content (PL)
|
Polish | 1.2 KB | |
| 2023-10-26 16:35 |
Legal Proceedings Report
Decyzja o ochronie patentowej na wynalazek - Content (PL)
|
Polish | 1.2 KB | |
| 2023-08-07 12:11 |
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
|
Polish | 1.4 KB | |
| 2023-08-07 12:08 |
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
|
Polish | 1.8 KB | |
| 2023-08-07 12:04 |
Registration Form
Decyzja o ochronie patentowej na wynalazek - Content (PL)
|
Polish | 1.2 KB | |
| 2023-08-07 12:01 |
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
|
Polish | 1.2 KB | |
| 2023-08-02 13:48 |
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
|
Polish | 1.1 KB | |
| 2023-08-02 13:45 |
Legal Proceedings Report
Decyzja o ochronie patentowej na wynalazek - Content (PL)
|
Polish | 1.2 KB | |
| 2023-08-01 15:06 |
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
|
Polish | 1.2 KB | |
| 2023-08-01 15:04 |
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
|
Polish | 1.2 KB | |
| 2023-06-30 17:30 |
Declaration of Voting Results & Voting Rights Announcements
Wykaz akcjonariuszy posiadających co najmniej 5% głosów na ZWZ READ-GENE S.A. w…
|
Polish | 584 bytes | |
| 2023-06-29 13:27 |
Director's Dealing
powiadomienie_o_transakcjach_-_zmiana.pdf
|
Polish | 11.9 KB |
Automate Your Workflow. Get a real-time feed of all Read Gene Spolka Akcyjna filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Read Gene Spolka Akcyjna via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
